PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | -20.0% | 11,200 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +15.4% | 11,200 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -50.0% | 11,200 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | +188.9% | 11,200 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -50.0% | 11,200 | -38.8% | 0.00% | – |
| Q2 2019 | $18,000 | -97.0% | 18,300 | -96.1% | 0.00% | – |
| Q1 2019 | $594,000 | -38.8% | 471,360 | +57.5% | 0.00% | – |
| Q4 2018 | $970,000 | +49.9% | 299,363 | +11.1% | 0.00% | – |
| Q3 2018 | $647,000 | +10.0% | 269,567 | +28.2% | 0.00% | – |
| Q2 2018 | $588,000 | +833.3% | 210,200 | +1468.7% | 0.00% | – |
| Q1 2018 | $63,000 | -91.7% | 13,400 | -86.2% | 0.00% | – |
| Q1 2017 | $760,000 | -28.2% | 97,167 | +12.4% | 0.00% | – |
| Q4 2016 | $1,059,000 | -28.9% | 86,471 | -9.6% | 0.00% | – |
| Q3 2016 | $1,490,000 | +34.4% | 95,617 | +4.7% | 0.00% | – |
| Q2 2016 | $1,109,000 | – | 91,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
| NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
| Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
| DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
| RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
| DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
| BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
| Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
| Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
| Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |